BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Panic Disorder

Below is an extended Panic Disorder patents listing. Click here to return to the Panic Disorder main in depth entry.

Patents :

US Patent No.Title
7381725 Pyridazine derivatives as ligands for GABA receptors
7393858 Tetrahydropyran compounds as tachykinin antagonists
7393934 Human G-protein chemokine receptor (CCR5) HDGNR10
7396326 Ferrofluidic cooling and acoustical noise reduction in magnetic stimulators
7396542 Stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof
7396834 4(Phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
7396853 2-phenyl-3,3,3-trifluoro-2-hydroxy-propionic acid derivatives
7396857 Therapeutic combinations for the treatment or prevention of depression
7398213 Method and system for diagnosing pathological phenomenon using a voice signal
7402687 Dihydrobenzofuran derivatives and uses thereof
7402698 Secondary amino-and cycloamino-cycloalkanol derivatives and methods of their use
7393845 Heteroaryl derivates, their preparation and use
7392167 Disease simulation system and method
7390903 Thieno-pyridine derivatives as allosteric enhancers of the GABA.sub.B receptors
7381726 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
7381741 3-amino-2-phenylpyrrolidine derivatives
7381747 Alpha 2 delta ligands for post-traumatic stress disorder
7381800 Antibodies to HBIMF63 polypeptide
7381826 Crystalline forms of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4- -yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone
7384934 Piperazine substituted aryl benzodiazepines
7384941 2-(phenoxymethyl)-and 2-(phenylthiomethyl)-morpholine derivatives for use as selective norepinephrine reuptake inhibitors
7384943 Substituted chroman derivatives
7384983 Inhibitor of monoamine uptake
7388023 Amino acids with affinity for the .alpha.2.delta.-protein
7407966 Thienopyridinone compounds and methods of treatment
7407970 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
7421297 Monopolar stimulation assembly including at least one remote electrode
7423037 Morpholine derivatives as norepinephrine reuptake inhibitors
7423050 Pyridinoylpiperidines as 5-HT.sub.1F agonists
7423054 Therapeutic pyrazolo[3,4-b]pyridines and indazoles
7423144 Purine Derivatives as adenosine A.sub.1 receptor agonists and methods of use thereof
7423179 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
7425556 Compounds and uses thereof
7427600 Active agent delivery systems and methods for protecting and administering active agents
7429569 Compositions and methods for the regulation of homocysteine levels within the body
7429607 5-HT.sub.2B receptor antagonists
7420044 Nucleic acid and protein homologs and uses thereof
7420033 Composition of lactoferrin related peptides and uses thereof
7419986 Antidepressant azaheterocyclylmethyl derivatives of heterocycle-fused benzodioxans
7410493 Method and device for the treatment of anxiety disorders
7410941 Methods for treatment of neurodegenerative conditions by peripherally administered erythropoietin
7410970 Substituted 1,4,-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
7411051 Antibodies to HDPPA04 polypeptide
7411054 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor
7411069 Doxepin analogs and methods of use thereof
7414052 Phenylaminopropanol derivatives and methods of their use
7414059 Pyrazolyl and imidazolyl pyrimidines as CRF antagonists
7417043 Modulators of dopamine neurotransmission
7419980 Fused-aryl and heteroaryl derivatives and methods of their use
7429665 Heteroaromatic quinoline compounds
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional